Novo Nordisk A/S | NOVOB - Cost Of Sales


Novo Nordisk reported DKK15.15B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Bausch Health Companies USD 1.03B 284M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Novo Nordisk DKK 15.15B 2.3B Dec/2025
Novo Nordisk DKK 1.95B 10.94B Jun/2025
Pacira USD 54.62M 6.02M Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Supernus Pharmaceuticals USD 47.53M 4.24M Dec/2025